Celldex Therapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by Anthony S. Marucci, with a market cap of $1.8B. As of Q3 2025, 106% of shares are held by 177 institutional investors, with Kynam Capital Management, LP as the largest holder at 9.19%.
Overview of institutional ownership in CLDX as of Q3 2025 with a market cap of $1.7B
Based on market cap of $1.7B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in CLDX as of Q3 2025
| Institution | Position Value |
|---|---|
K Kynam Capital Management, LP Hedge Fund•Long/Short | $157.8M 11.75% of portfolio |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $150.0M 0.03% of portfolio |
B BlackRock, Inc. Institution | $142.4M 0.00% of portfolio |
FMR LLC Institution | $128.4M 0.01% of portfolio |
VANGUARD GROUP INC Institution | $102.3M 0.00% of portfolio |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | $100.7M 0.23% of portfolio |
B Bellevue Group AG Institution | $92.0M 1.92% of portfolio |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | $78.3M 3.82% of portfolio |
STATE STREET CORP Institution | $73.5M 0.00% of portfolio |
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | $61.6M 0.01% of portfolio |
Institutional buying and selling activity for CLDX in Q3 2025
| Institution | Net Bought |
|---|---|
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | +$28.3M +1.1M shares |
B BRAIDWELL LP Hedge Fund•Multi-Strategy | +$15.3M +591.7K shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | +$14.7M +567.7K shares |
E EVENTIDE ASSET MANAGEMENT, LLC Long Only Manager | +$13.0M +502.9K shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | +$12.9M +498.0K shares |
STATE STREET CORP Institution | +$11.3M +436.6K shares |
Eversept Partners, LLC Hedge Fund•Long/Short | +$8.2M +315.2K shares |
GOLDMAN SACHS GROUP INC Institution | +$7.8M +302.0K shares |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | +$7.8M +300.0K shares |
B Bellevue Group AG Institution | +$6.5M +250.1K shares |
| Institution | Net Sold |
|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | −$37.1M −1.4M shares |
Woodline Partners LP Hedge Fund•Long/Short | −$33.7M −1.3M shares |
Vestal Point Capital, LP Hedge Fund•Long/Short | −$14.1M −545.0K shares |
FMR LLC Institution | −$12.3M −477.0K shares |
Logos Global Management LP Hedge Fund•Long/Short | −$12.2M −600.0K shares |
UBS Group AG Institution | −$11.0M −424.8K shares |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | −$10.9M −421.7K shares |
D D. E. Shaw & Co., Inc. Institution | −$10.0M −388.3K shares |
MORGAN STANLEY RIA/Wealth | −$9.0M −349.6K shares |
R READYSTATE ASSET MANAGEMENT LP Hedge Fund•Multi-Strategy | −$7.5M −288.5K shares |
Institutions that initiated new positions or completely exited CLDX in Q3 2025
| Institution | Position Value |
|---|---|
B BRAIDWELL LP Hedge Fund•Multi-Strategy | $15.3M 591.7K shares |
Propel Bio Management, LLC Hedge Fund•Sector | $4.0M 155.0K shares |
S Simplify Asset Management Inc. Institution | $2.2M 85.0K shares |
D DAFNA Capital Management LLC Hedge Fund•Event Driven | $634.3K 24.5K shares |
Cetera Investment Advisers RIA/Wealth | $256.2K 9.9K shares |
T TRANSCEND WEALTH COLLECTIVE, LLC RIA/Wealth | $239.0K 9.2K shares |
A Argent Trust Co Institution | $219.4K 8.5K shares |
B BRYN MAWR TRUST CO/PA Institution | $42.2K 1.6K shares |
O Optiver Holding B.V. Institution | $6.8K 264.0 shares |
Strategic Advocates LLC RIA/Wealth | $3.4K 130.0 shares |
| Institution | Previous Position |
|---|---|
Logos Global Management LP Hedge Fund•Long/Short | $12.2M 600.0K shares |
A AXA Institution | $3.8M 185.1K shares |
Cinctive Capital Management LP Hedge Fund•Multi-Strategy | $2.8M 138.0K shares |
Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy | $2.4M 118.8K shares |
Trexquant Investment LP Hedge Fund•Quant | $2.3M 112.5K shares |
Exome Asset Management LLC Hedge Fund•Sector | $1.5M 73.0K shares |
Sovran Advisors, LLC RIA/Wealth | $842.0K 39.5K shares |
TWO SIGMA ADVISERS, LLC Hedge Fund•Multi-Strategy | $826.2K 40.6K shares |
P Perbak Capital Partners LLP Institution | $822.3K 40.4K shares |
SPRINGBOK CAPITAL MANAGEMENT, LLC Fund of Funds | $632.2K 31.1K shares |
Institutions with the largest Call and Put options positions in CLDX as of Q3 2025
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $845.9K 327.0 contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $835.6K 323.0 contracts |
W WOLVERINE TRADING, LLC Institution | $468.8K 179.0 contracts |
Walleye Trading Advisors, LLC Hedge Fund•Multi-Strategy | $152.6K 59.0 contracts |
Walleye Trading LLC RIA/Wealth | $147.5K 57.0 contracts |
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $2.2M 839.0 contracts |
LEUCADIA NATIONAL CORP Institution | $2.1M 797.0 contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $962.4K 372.0 contracts |
J JANE STREET GROUP, LLC Institution | $315.6K 122.0 contracts |
Walleye Trading Advisors, LLC Hedge Fund•Multi-Strategy | $77.6K 30.0 contracts |
Walleye Trading LLC RIA/Wealth | $62.1K 24.0 contracts |
Institutions with CLDX as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
K Kynam Capital Management, LP Hedge Fund•Long/Short | 11.75% $157.8M |
5 5AM Venture Management, LLC Institution | 4.71% $12.9M |
Propel Bio Management, LLC Hedge Fund•Sector | 4.01% $4.0M |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | 3.82% $78.3M |
TSP Capital Management Group, LLC Private Equity | 2.60% $9.7M |
Eversept Partners, LLC Hedge Fund•Long/Short | 2.29% $29.9M |
N Novo A/S Institution | 2.04% $31.0M |
Polygon Management Ltd. Hedge Fund•Multi-Strategy | 1.98% $7.9M |
B Bellevue Group AG Institution | 1.92% $92.0M |
Vestal Point Capital, LP Hedge Fund•Long/Short | 1.58% $31.2M |
Discover hedge funds investing in CLDX
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $157.8M | 11.75% | |
Biotechnology Healthcare | $131.1M | 9.76% | |
Biotechnology Healthcare | $117.0M | 8.71% |
We use cookies for analytics. See our Privacy and Cookie Policy.